Fox Run Management L.L.C. Purchases New Shares in Bath & Body Works, Inc. (NYSE:BBWI)

Fox Run Management L.L.C. purchased a new stake in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 19,817 shares of the company's stock, valued at approximately $768,000.

A number of other large investors have also recently modified their holdings of BBWI. SRS Capital Advisors Inc. raised its position in Bath & Body Works by 99.7% during the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock valued at $26,000 after purchasing an additional 329 shares in the last quarter. Golden State Wealth Management LLC bought a new stake in shares of Bath & Body Works in the fourth quarter valued at about $26,000. UMB Bank n.a. lifted its stake in Bath & Body Works by 58.8% in the fourth quarter. UMB Bank n.a. now owns 905 shares of the company's stock worth $35,000 after acquiring an additional 335 shares during the period. Lindbrook Capital LLC grew its holdings in Bath & Body Works by 81.9% during the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock worth $37,000 after acquiring an additional 431 shares in the last quarter. Finally, Smartleaf Asset Management LLC increased its position in Bath & Body Works by 135.0% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,013 shares of the company's stock valued at $39,000 after purchasing an additional 582 shares during the period. Hedge funds and other institutional investors own 95.14% of the company's stock.

Bath & Body Works Stock Performance

NYSE BBWI traded down $0.97 during trading hours on Friday, reaching $30.93. The stock had a trading volume of 3,958,558 shares, compared to its average volume of 4,493,882. Bath & Body Works, Inc. has a 52-week low of $26.21 and a 52-week high of $52.99. The stock has a fifty day moving average of $35.21 and a 200 day moving average of $34.03. The stock has a market cap of $6.63 billion, a P/E ratio of 7.54, a price-to-earnings-growth ratio of 0.92 and a beta of 1.89.

Remove Ads

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings data on Thursday, February 27th. The company reported $2.09 EPS for the quarter, beating the consensus estimate of $2.04 by $0.05. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The business had revenue of $2.79 billion for the quarter, compared to the consensus estimate of $2.78 billion. On average, equities research analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Shareholders of record on Friday, February 21st were paid a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, February 21st. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.59%. Bath & Body Works's payout ratio is currently 21.98%.

Bath & Body Works announced that its board has approved a stock repurchase program on Thursday, February 27th that authorizes the company to buyback $500.00 million in outstanding shares. This buyback authorization authorizes the company to purchase up to 6.4% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's leadership believes its shares are undervalued.

Analyst Ratings Changes

A number of research firms have recently issued reports on BBWI. Citigroup upgraded shares of Bath & Body Works from a "neutral" rating to a "buy" rating and increased their price objective for the company from $40.00 to $48.00 in a research note on Friday, February 28th. Robert W. Baird lifted their price target on Bath & Body Works from $45.00 to $47.00 and gave the company an "outperform" rating in a report on Friday, February 28th. Piper Sandler upped their price objective on Bath & Body Works from $36.00 to $39.00 and gave the stock a "neutral" rating in a research note on Monday, January 6th. Argus reiterated a "hold" rating on shares of Bath & Body Works in a research note on Friday, January 10th. Finally, Wells Fargo & Company raised shares of Bath & Body Works from an "equal weight" rating to an "overweight" rating and increased their price target for the company from $42.00 to $48.00 in a research report on Friday, January 10th. Five research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, Bath & Body Works presently has an average rating of "Moderate Buy" and a consensus target price of $45.06.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.